Africa: WHO Recommends Long-Acting Cabotegravir for HIV Prevention

[WHO] WHO today released new guidelines for the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV and called for countries to consider this safe and highly effective prevention option for people at substantial risk of HIV infection.
Source: AllAfrica News: HIV-Aids and STDs - Category: Infectious Diseases Source Type: news